Stay updated on Itolizumab in Lupus Nephritis Clinical Trial
Sign up to get notified when there's something new on the Itolizumab in Lupus Nephritis Clinical Trial page.

Latest updates to the Itolizumab in Lupus Nephritis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 and removed prior notices (government-funding notice and Revision: v3.4.1). These are maintenance updates that do not affect study data, eligibility, or results on the page.SummaryDifference0.7%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.7%

- Check28 days agoChange DetectedThe page history shows new UI elements including a 'Show glossary' option, color-diff indicators (green additions, red deletions), and an updated revision label to v3.4.0, as well as a capitalization change from 'No FEAR Act data' to 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check42 days agoChange DetectedNew revision label v3.3.4 appears replacing v3.3.3 in the history, a minor version update with no user-facing content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedNew site revision note added: Revision: v3.3.3. The HHS Vulnerability Disclosure entry and the previous Revision: v3.3.2 reference were removed.SummaryDifference0.2%

- Check85 days agoChange DetectedA new revision entry v3.3.2 was added to the Record History, replacing v3.3.1; no study data or user-facing content appears to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Itolizumab in Lupus Nephritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Itolizumab in Lupus Nephritis Clinical Trial page.